Skip to content

Value of Tomosynthesis for the Detection of Sacro-iliitis (TOMOS SI)

Value of Tomosynthesis for Detection of Sacro-iliitis: a Prospective Comparative Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03689881
Acronym
TOMOS SI
Enrollment
30
Registered
2018-10-01
Start date
2018-10-04
Completion date
2020-12-31
Last updated
2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacroiliitis

Keywords

Sacroiliitis, SI joint, tomosynthesis, CT, Xray

Brief summary

Spondyloarthropathies (SpAs) are chronic inflammatory diseases encompassing ankylosing spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthropathy, and undifferentiated SpA. In 2001, the estimated prevalence of SpA was 1.5% worldwide. Sacroiliitis is a condition caused by inflammation within the sacroiliac joint. It is the most frequent damage of SpA depicted at imaging evaluation. Conventional radiography (X-ray) is usually used to depict the structural changes associated with sacroiliitis. However further evaluation often requires additionnal computed tomography (CT). Tomosynthesis is an Xray-based imaging technology which allows reconstruction of multiple section images from a set of projection images acquired as the x-ray tube moves along a prescribed path. The advantagee of tomosynthesis is the significant reduction of radiation dose exposure compared to CT Tomosynthesis is currently used in the field of breast imaging and pneumology. Very few studies have examined the value of tomosynthesis for osteoarticular imaging. The study aims at evaluating the diagnostic performances of tomosynthesis as compared to standard X-ray and CT, in patients with a clinical suspicion of sacroiliitis. the investigators hypothesize that tomosynthesis is superior to conventional radiography for detection of sacroiliitis and is at least equal to CT with lower irradiation.

Detailed description

Consecutive patients referred to CT for exploration of sacrollitis will be included and investigated with standard radiography, CT and tomosynthesis of SI joints. Imaging examinations will be performed at day of enrollment as follow : X-ray and CT as standard management and tomosynthesis as additional evaluation. CT will be considered as the reference standard Sacroiliitis will be assessed in a centralized, blind and randomized retrospective reading of all imaging modalities by two independent radiologists. Diagnostic performances and radiation doses of tomosynthesis will be compared to those of standard CT and X-ray examinations.

Interventions

DEVICETomosynthesis of SI joints

All patients will undergo additional tomosynthesis performed per study protocol along with Xray and CT performed as part of standard imaging evaluation of sacroillitis. Tomosynthesis of SI joints will be performed on a digital Tomosynthesis system (PLATINUM dRF v2 DMS/APELEM), with a single acquisition followed by coronal image reconstruction.

Sponsors

DMS Apelem
CollaboratorINDUSTRY
Thales
CollaboratorUNKNOWN
Digisens
CollaboratorUNKNOWN
Medecom
CollaboratorUNKNOWN
BPIfrance
CollaboratorOTHER
European Regional Development Fund
CollaboratorOTHER
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 and over referred for suspected sacroiliitis. * Patients who have entered into their participation agreement by signing the informed consent form. * Patient affiliated to a social security scheme or beneficiary.

Exclusion criteria

* Pregnant or lactating women. * Vulnerable people according. * Major people placed under guardianship or curatorship.

Design outcomes

Primary

MeasureTime frameDescription
Presence of bone erosions and other structural lesions of SI joints1 day of enrollmentsacroiliitis will be assessed independently for each imaging modality according to the modified New York criteria

Secondary

MeasureTime frameDescription
radiation dose1 day of enrollmentRadiation dose will be measured for each imaging evaluation and calculated as the effective dose in millisievert (mSv).
inter reader agreement for the evaluation of sacroiliitis at tomosynthesisat the end of patients enrollmentInter reader agreement will be measured at retrospective evaluation.

Countries

France

Contacts

Primary ContactCatherine Cyteval, MD, PhD
c-cyteval@chu-montpellier.fr+ 33 4 67 33 81 78

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026